Compare INDV & OSIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDV | OSIS |
|---|---|---|
| Founded | 1994 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | 2014 | 1997 |
| Metric | INDV | OSIS |
|---|---|---|
| Price | $35.53 | $194.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $49.00 | ★ $273.29 |
| AVG Volume (30 Days) | ★ 1.3M | 172.0K |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | 2.76 |
| EPS | 1.67 | ★ 8.95 |
| Revenue | ★ $1,239,000,000.00 | $1,089,286,000.00 |
| Revenue This Year | $7.50 | $6.80 |
| Revenue Next Year | $5.07 | $6.40 |
| P/E Ratio | ★ $21.23 | $21.60 |
| Revenue Growth | 4.29 | ★ 13.35 |
| 52 Week Low | $23.55 | $186.50 |
| 52 Week High | $42.81 | $311.72 |
| Indicator | INDV | OSIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 39.74 |
| Support Level | $33.45 | $186.50 |
| Resistance Level | $35.54 | $206.19 |
| Average True Range (ATR) | 0.96 | 5.34 |
| MACD | 0.10 | 0.35 |
| Stochastic Oscillator | 38.21 | 29.44 |
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.